Abstract:Sepsis represents a syndromic response to infection and frequently acts as a common pathway leading to fatality in the context of various infectious diseases globally. The pathology of severe sepsis is marked by an excess of inflammation and activated coagulation. A substantial contributor to mortality in sepsis patients is widespread microvascular thrombosis-induced organ dysfunction. Multiple lines of evidence support the notion that sepsis induces endothelial damage, leading to the release of glycosaminoglycans, potentially causing microvascular dysfunction. This review aims to initially elucidate the relationship among endothelial damage, excessive inflammation, and thrombosis in sepsis. Following this, we present a summary of the involvement of glycosaminoglycans in coagulation, elucidating interactions among glycosaminoglycans, platelets, and inflammatory cells. In this section, we also introduce a reasoned generalization of potential signal pathways wherein glycosaminoglycans play a role in clotting. Finally, we discuss current methods for detecting microvascular conditions in sepsis patients from the perspective of glycosaminoglycans. In conclusion, it is imperative to pay closer attention to the role of glycosaminoglycans in the mechanism of microvascular thrombosis in sepsis. Dynamically assessing glycosaminoglycan levels in patients may aid in predicting microvascular conditions, enabling the monitoring of disease progression, adjustment of clinical treatment schemes, and mitigation of both acute and long-term adverse outcomes associated with sepsis. Not applicable. All the data supporting in this article can be found in publicly available datasets. All authors drafted the article and revised it critically for important intellectual content and approved the final manuscript to be published. None declared. Received: 14 June 2023 Accepted: 23 December 2023 Accepted Manuscript online: 19 January 2024 Article published online: 15 February 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology

Endothelial Cell Dysfunction and Targeted Therapeutic Drugs in Sepsis

Microvascular responses to sepsis: clinical significance

The effects of sepsis on endothelium and clinical implications

Inflammation, endothelium, and coagulation in sepsis

Endothelial and Microcirculatory Function and Dysfunction in Sepsis

Endothelial dysfunction and immunothrombosis in sepsis

Inflammation, Sepsis, and the Coagulation System

Glycosaminoglycans: Participants in Microvascular Coagulation of Sepsis

Endothelial Cell Dysfunction Due to Molecules Secreted by Macrophages in Sepsis

Bench-to-bedside review: Endothelial cell dysfunction in severe sepsis: a role in organ dysfunction?

Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis

Endothelial Activation and Microcirculatory Disorders in Sepsis

Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis

Molecular basis of endothelial dysfunction in sepsis

Macrophage S1PR2 Drives Sepsis-induced Immunosuppression by Exacerbating Mitochondrial Fragmentation

Defensins and sepsis.

Defensins and Sepsis

Endothelial Responses in Sepsis

Thromboinflammation in acute injury: infections, heatstroke, and trauma

Molecular Pathways in Sepsis Pathogenesis: Recent Advances and Therapeutic Avenues